We have previously demonstrated that short-term infusion of calcitonin gene-related peptide (CGRP) has beneficial effects in congestive heart failure. The effects of prolonged infusion of CGRP on hemodynamic functions, plasma hormones and renal blood flow were studied in 9 patients with congestive heart failure (New York Heart Association class III or IV, ejection fraction <35%). Hemodynamic variables were measured at 30-minute intervals for 8 hours during CGRP infusion (8 ng/kg/ min) and for 2 hours after discontinuation. CGRP caused a decrease in right atrial (28%, p < 0.05), pulmonary artery (22%, p < 0.02), pulmonary artery wedge (37%, p < 0.001) and systemic arterial (18%, p < 0.05) pressures. Systemic vascular resistance decreased more than pulmonary vascular resistance. Cardiac output (72%, p < 0.001) and stroke volume (60%, p < 0.02) increased. Heart rate did not change. There was no evidence of tolerance throughout the infusion. The hemodynamic effects were lost within 30 minutes of stopping CGRP. Renal blood flow (34%, p < 0.01) and glomerular filtration rate (43%, p < 0.01) increased. Atrial natriuretic peptide decreased (p < 0.05), while plasma cortisol (p < 0.02) increased. Plasma epinephrine, norepinephrine, renin activity, aldosterone and growth hormone were unchanged. It is concluded that in patients with severe congestive heart failure, CGRP has sustained beneficial effects on hemodynamic functions and has no adverse effects on hormones. Unlike many other vasodilators, CGRP also increases renal blood flow and glomerular filtration.
Bibliographical noteFunding Information:
From the Department of Cardiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India; Cattedra de Cardiologia Di Chimica, Universita di Brescia, Spedali Civili, Brescia, Italy; Department of Cardiac Medicine, National Heart and Lung Institute, Dovehouse Street, London, United Kingdom. This work was supported in part by a grant from the Indian Council of Medical Research, New Delhi, India. Manuscript received October 24,199O; revised manuscript received December 13, 1990; and accepted December 16.
Copyright 2018 Elsevier B.V., All rights reserved.